ImExHS Limited

A$0.34As of Sun 8 Nov 2026, 12:00 UTC
ASX:IMEHealthcare
Country Australia
PE (Fwd) •••
TSR 8Y CAGR (18.10%)
Div yield —
ROE 1.19%
Diagnostics & Research
Beta (5Y) 0.78
PE TTM 99.65
TSR TTM 27.78%
Mkt cap A$18.77M
ROIC 1.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.356
3.20%
(37.81%)
Hold 1|11|8|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
6.57%
10.66%
15.70%
32.16%
Revenue$M
1.046
1.058
1.105
1.095
1.41%
4.55%
11.01%
6.43%
Peers (US$12.89M)
Cap (US$)
PE
12.76M
—
Capital
TTM
5Y
10Y
Leveragex
0.233
0.038
0.020
EBIT/Intx
2.551
0.232
0.179
Own earn%
23.79
11.17
5.12
Sh yield%
31.34
24.32
24.86
Owners
Insiders/Inst%
5.72
28.38
Short interest%
3.01
SBC / revenue%
0.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–34
$1 testx
0.0
Incr. ROIC%
1